VivoSeq
Other

Major Abdominal Surgery

0

Pipeline Programs

3

Active Trials

2

Companies Involved

Major Abdominal Surgery is an early-stage landscape with 0 programs across 2 companies. The most active players are GSK, Pfizer.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

12/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed11 · 65%
Recruiting2 · 12%
Not yet recruiting1 · 6%
Unknown status1 · 6%
Withdrawn1 · 6%
Terminated1 · 6%

Trial Activity

17 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)